Crispr Therapeutics Ag (CRSP)

Apr 25, 2025

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards? - Nasdaq

Apr 25, 2025

Apr 25, 2025

Legal & General Group Plc Has $3.85 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 25, 2025

Apr 24, 2025

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Crispr Therapeutics Benefits From Diverse Gene Editing Portfolio; Positive Long-Term Outlook - Morningstar

Apr 24, 2025

Apr 24, 2025

Prediction: 1 Biotech Stock That Could Surpass Pfizer by 2030 - 24/7 Wall St.

Apr 24, 2025

Apr 24, 2025

Capital International Sarl Has $7.36 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 24, 2025

Apr 23, 2025

Wells Fargo & Company MN Has $8.66 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 23, 2025

Apr 23, 2025

CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know - MSN

Apr 23, 2025

Apr 23, 2025

Leerink Partnrs Issues Negative Estimate for CRSP Earnings - MarketBeat

Apr 23, 2025

Apr 23, 2025

‘Incoming Regulatory Tailwinds’ to Spur 90% Upside for CRISPR Therapeutics Stock, Says BMO Capital - Yahoo Finance

Apr 23, 2025

Apr 23, 2025

Capital International Investors Purchases 816,789 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 23, 2025

Apr 22, 2025

Jump Financial LLC Increases Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 22, 2025

Apr 22, 2025

Advisory Services Network LLC Sells 7,629 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 22, 2025

Apr 22, 2025

Crispr Therapeutics AG: Promising Growth with Casgevy Launch and Innovative Pipeline - TipRanks

Apr 22, 2025

Apr 21, 2025

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It - MSN

Apr 21, 2025

Apr 21, 2025

Geode Capital Management LLC Has $39.41 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 21, 2025

Apr 20, 2025

5 Monster Stocks -- Such as Coupang -- to Hold for the Next 10 Years - The Motley Fool

Apr 20, 2025

Apr 19, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Shares Down 4%Should You Sell? - MarketBeat

Apr 19, 2025

Apr 18, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by Reynders McVeigh Capital Management LLC - MarketBeat

Apr 18, 2025

Apr 18, 2025

CRISPR Therapeutics stock pops following disclosure of RFK Jr. investment - MSN

Apr 18, 2025

Apr 17, 2025

CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN

Apr 17, 2025

Apr 17, 2025

BofA Adjusts Price Target on CRISPR Therapeutics to $80 From $86, Keeps Buy Rating - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Crispr Therapeutics AG (CRSP) Receives a Buy from Bank of America Securities - The Globe and Mail

Apr 17, 2025

Apr 17, 2025

BofA Adjusts Price Target for Crispr Therapeutics (CRSP) to $80 | CRSP Stock News - GuruFocus

Apr 17, 2025

Apr 17, 2025

Vanguard Group Inc. Acquires 10,579 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 17, 2025

Apr 16, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) Sees 25% Price Increase Over Last Week - Yahoo Finance

Apr 16, 2025

Apr 15, 2025

How To Trade (CRSP) - news.stocktradersdaily.com

Apr 15, 2025

Apr 15, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $73.11 Consensus Target Price from Analysts - MarketBeat

Apr 15, 2025

Apr 14, 2025

Gene Therapy Market Anticipated to Witness 20% CAGR Growth by 2029: Top Key Players like Novartis, Roche, CRISPR Therapeutics - PharmiWeb.com

Apr 14, 2025

Apr 14, 2025

CRISPR Therapeutics' (CRSP) Buy Rating Reiterated at Needham & Company LLC - MarketBeat

Apr 14, 2025

Apr 14, 2025

California Public Employees Retirement System Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 14, 2025

Apr 12, 2025

3 Magnificent Stocks That Could Double or More by 2030 - Yahoo Finance

Apr 12, 2025

Apr 12, 2025

443,536 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by Norges Bank - MarketBeat

Apr 12, 2025

Apr 11, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Sets New 12-Month LowTime to Sell? - MarketBeat

Apr 11, 2025

Apr 11, 2025

LPL Financial LLC Buys 42,232 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Apr 11, 2025

Apr 11, 2025

CRISPR Therapeutics: Is This Biotech Surge Here to Stay? - timothysykes.com

Apr 11, 2025

Apr 11, 2025

First Week of May 30th Options Trading For CRISPR Therapeutics (CRSP) - Nasdaq

Apr 11, 2025

Apr 11, 2025

Goldman Sachs maintains Neutral on CRISPR Therapeutics stock By Investing.com - Investing.com South Africa

Apr 11, 2025

Apr 11, 2025

Goldman Sachs maintains Neutral on CRISPR Therapeutics stock - Investing.com

Apr 11, 2025

Apr 11, 2025

47,840 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by ExodusPoint Capital Management LP - MarketBeat

Apr 11, 2025

Apr 11, 2025

Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals? - AOL.com

Apr 11, 2025